MannKind Corporation | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (316)

View All

Latest Posts

About This Stock More About This Stock
MannKind Initiated With A Buy, $3 Price Target At BTIG
Article By: The Fly
Tuesday, May 14, 2019 7:45 AM EDT
BTIG analyst Robert Hazlett initiated coverage of MannKind with a Buy rating and $3 price target.
In this article: MNKD
Read
Maxim Wanted Bigger Capital Raise, Downgrades MannKind To Hold
Article By: The Fly
Wednesday, November 1, 2017 3:02 PM EDT
Maxim analyst Jason Kolbert downgraded MannKind to Hold from Buy saying he believes the company has less than two operating quarters of cash on hand.
In this article: MNKD
Read
MannKind Corporation Reports Annual Net Profit
Article By: KKD Healthcare Analytics
Thursday, March 30, 2017 12:32 PM EDT
MannKind Corporation recently reported its financial results for the fourth quarter and full year. The company’s total revenue for the quarter stood at $12.4 million. Its net income for the quarter was reported at $54 million.
In this article: MNKD Also: SNY
Read
Most Active Stock Options For End Of Day March 7, 2017
Article By: The Options Insider
Tuesday, March 7, 2017 5:37 PM EDT
The most active stock options for end of day Tuesday: GM, MNKD, MJN, BMY and JCP.
In this article: GM, MNKD, MJN, BMY, JCPNQ
Read
MannKind Corporation Shares Slip Despite Lawsuit Dismissal
Article By: ValueWalk
Thursday, August 25, 2016 4:15 PM EDT
MannKind shares edged lower by as much as 2.23% to 85 cents per share during regular trading hours on Thursday after the company announced that the class-action lawsuit filed against it had been dismissed.
In this article: MNKD
Read
All Posts

Latest Tweets for $MNKD

No tweets yet!

PARTNER HEADLINES

$MNKD

Comments Status Updates
MannKind Initiated With a Buy, $3 Price Target at BTIG
Craig Newman • 5/17/2019 3:13:50 PM

I'd take $3 in a buy out right now. $MNKD

MannKind Corporation: Why The Mealtime Insulin Market Will Expand Drastically
David Patterson • 6/30/2017 7:09:05 PM

Good article on #MannKind ($MNKD). I agree that the #insulin market will continue to grow. Before investing in this space, it's important to better understand what insulin is, how it works, and why demand is growing: https://scribeschool.net/how-insulin-works.html

1 to 2 of 2 comments